{"id":1383,"date":"2018-02-21T11:03:21","date_gmt":"2018-02-21T11:03:21","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=1383"},"modified":"2018-02-21T11:05:13","modified_gmt":"2018-02-21T11:05:13","slug":"focus-pharmaceuticals-barcode-errors-8-medicinal-products","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products","title":{"rendered":"MHRA issue “Class 4” drug alert warning for Focus Pharmaceuticals after barcode errors found on 8 medicinal products"},"content":{"rendered":"

The Medicines and Healthcare Products Regulatory Agency (MHRA) issued a Class 4 (caution in use) warning over eight Focus Pharmaceutical medicinal products after a problem was found with the barcodes.<\/p>\n

The packaging fault may interfere with prescriptions as the wrong product may be identified when they’re scanned.<\/p>\n

The medicines themselves have no reported faults<\/strong> and the rest of the packaging including the name, strength and pharmaceutical form of the medicine is correct as far as the manufacturer and the MHRA are aware.
\n
\nThe drug alert affects all those in the chain from the manufacturer, supplier to the distributor. Anyone processing the drug by use of a robotic or automated dispensing system is requested to manually sort the packets instead.<\/p>\n

Packaging errors that don’t affect the product itself like this may seem insignificant but there is still a potential risk of damage. Medicines are, after all, drugs. For it to have medicinal properties in treating ailments, it needs to be carefully measured and administered<\/strong>. Simple errors like not being able to find the right drug could create a much bigger problem down the line.<\/p>\n

If automated systems can#t \u2018find\u2019 the required medicine, the patient may not be able to get the treatment they need. One of the affected medicines is Pregabiln<\/em>; a drug used to control seizures, treat nerve pain and to treat fibromyalgia. With the required drug ‘unavailable’, an alternative may be used. However, an alternative may not have the same effects or the same side-effects, and this issue could make it more risky for a patient<\/strong>.<\/p>\n

The MHRA last updated its guidelines on medicines packaging in April 2016, noting the importance of accuracy so that prescription and supply of medicines are effective and efficient.<\/p>\n

Generally speaking, there appears to be an increase in pharmaceutical products being recalled, according to Alexander Gaffney. Any carelessness that affects the quality of the drug or its packaging can have devastating consequences as vulnerable and ill people rely on them.<\/p>\n

Image Credit: https:\/\/pixabay.com\/en\/barcode-bar-code-strip-code-code-3616\/<\/a><\/small><\/p>\n","protected":false},"excerpt":{"rendered":"

The Medicines and Healthcare Products Regulatory Agency (MHRA) issued a Class 4 (caution in use) warning over eight Focus Pharmaceutical medicinal products after a problem was found with the barcodes. The packaging fault may interfere with prescriptions as the wrong product may be identified when they’re scanned. The medicines themselves have no reported faults and … Continue reading MHRA issue “Class 4” drug alert warning for Focus Pharmaceuticals after barcode errors found on 8 medicinal products<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":1390,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[5],"tags":[20,24],"class_list":["post-1383","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical","tag-mhra","tag-prescription-drugs"],"yoast_head":"\nFocus Pharmaceuticals Barcode Errors Found On 8 Medicinal Products<\/title>\n<meta name=\"description\" content=\"The Medicines and Healthcare Products Regulatory Agency has issued a Class 4 (caution in use) warning over 8 Focus Pharmaceutical medicinal products after packaging barcode errors were found in selected batches.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Focus Pharmaceuticals Barcode Errors Found On 8 Medicinal Products\" \/>\n<meta property=\"og:description\" content=\"The Medicines and Healthcare Products Regulatory Agency has issued a Class 4 (caution in use) warning over 8 Focus Pharmaceutical medicinal products after packaging barcode errors were found in selected batches.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2018-02-21T11:03:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-02-21T11:05:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-large-min.png?fit=1200%2C680&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"680\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-large-min.png?fit=1200%2C680&ssl=1\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"headline\":\"MHRA issue “Class 4” drug alert warning for Focus Pharmaceuticals after barcode errors found on 8 medicinal products\",\"datePublished\":\"2018-02-21T11:03:21+00:00\",\"dateModified\":\"2018-02-21T11:05:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products\"},\"wordCount\":350,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/barcode-error-min.png?fit=725%2C250&ssl=1\",\"keywords\":[\"mhra\",\"prescription drugs\"],\"articleSection\":[\"Medical\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products\",\"name\":\"Focus Pharmaceuticals Barcode Errors Found On 8 Medicinal Products\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/barcode-error-min.png?fit=725%2C250&ssl=1\",\"datePublished\":\"2018-02-21T11:03:21+00:00\",\"dateModified\":\"2018-02-21T11:05:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"description\":\"The Medicines and Healthcare Products Regulatory Agency has issued a Class 4 (caution in use) warning over 8 Focus Pharmaceutical medicinal products after packaging barcode errors were found in selected batches.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/barcode-error-min.png?fit=725%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/barcode-error-min.png?fit=725%2C250&ssl=1\",\"width\":\"725\",\"height\":\"250\",\"caption\":\"barcode error alert\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MHRA issue “Class 4” drug alert warning for Focus Pharmaceuticals after barcode errors found on 8 medicinal products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles & Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Focus Pharmaceuticals Barcode Errors Found On 8 Medicinal Products","description":"The Medicines and Healthcare Products Regulatory Agency has issued a Class 4 (caution in use) warning over 8 Focus Pharmaceutical medicinal products after packaging barcode errors were found in selected batches.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products","og_locale":"en_GB","og_type":"article","og_title":"Focus Pharmaceuticals Barcode Errors Found On 8 Medicinal Products","og_description":"The Medicines and Healthcare Products Regulatory Agency has issued a Class 4 (caution in use) warning over 8 Focus Pharmaceutical medicinal products after packaging barcode errors were found in selected batches.","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products","og_site_name":"Group Action Lawyers","article_published_time":"2018-02-21T11:03:21+00:00","article_modified_time":"2018-02-21T11:05:13+00:00","og_image":[{"width":1200,"height":680,"url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-large-min.png?fit=1200%2C680&ssl=1","type":"image\/png"}],"author":"Admin","twitter_card":"summary_large_image","twitter_image":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-large-min.png?fit=1200%2C680&ssl=1","twitter_misc":{"Written by":"Admin","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products"},"author":{"name":"Admin","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"headline":"MHRA issue “Class 4” drug alert warning for Focus Pharmaceuticals after barcode errors found on 8 medicinal products","datePublished":"2018-02-21T11:03:21+00:00","dateModified":"2018-02-21T11:05:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products"},"wordCount":350,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-min.png?fit=725%2C250&ssl=1","keywords":["mhra","prescription drugs"],"articleSection":["Medical"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products","name":"Focus Pharmaceuticals Barcode Errors Found On 8 Medicinal Products","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-min.png?fit=725%2C250&ssl=1","datePublished":"2018-02-21T11:03:21+00:00","dateModified":"2018-02-21T11:05:13+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"description":"The Medicines and Healthcare Products Regulatory Agency has issued a Class 4 (caution in use) warning over 8 Focus Pharmaceutical medicinal products after packaging barcode errors were found in selected batches.","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-min.png?fit=725%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-min.png?fit=725%2C250&ssl=1","width":"725","height":"250","caption":"barcode error alert"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/focus-pharmaceuticals-barcode-errors-8-medicinal-products#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"MHRA issue “Class 4” drug alert warning for Focus Pharmaceuticals after barcode errors found on 8 medicinal products"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles & Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781","name":"Admin","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","caption":"Admin"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/admin"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/barcode-error-min.png?fit=725%2C250&ssl=1","jetpack-related-posts":[{"id":1282,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/histamine-alert-gentamicin-sulphate-active-pharmaceutical-ingredient","url_meta":{"origin":1383,"position":0},"title":"MHRA issues warning for Gentamicin Sulphate Active Pharmaceutical Ingredient over increased levels of histamine","author":"Admin","date":"17th January 2018","format":false,"excerpt":"The Medicines and Healthcare products Regulatory Agency (MHRA) has issued an alert over batches of Gentamicin Sulphate Active Pharmaceutical Ingredient (API) for trace contamination of histamine. The situation is reportedly not serious enough to warrant a recall. Gentamicin is a bactericidal used an as active ingredient for antibiotics. The MHRA\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"mhra issue histamine alert","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/mhra-histamine-alert-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/mhra-histamine-alert-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/mhra-histamine-alert-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/mhra-histamine-alert-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":849,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/diclo-sr-75-pain-relief-tablets-class-2-recall","url_meta":{"origin":1383,"position":1},"title":"Class 2 recall for Diclo-SR 75 pain-relief tablets","author":"Admin","date":"28th July 2017","format":false,"excerpt":"A Watford-based pharmaceutical company has issued a voluntary recall for batches of Diclo-SR 75 pain relief tablets - AKA diclofenac sodium. The tablets are commonly used for pain relief and swelling for arthritis, musculoskeletal disorders, gout and pain caused by injury or minor surgery. The tablets are classified in a\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"pain relief tablets recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":525,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/mirena-inserters-incorrectly-mounted-class-4-mhra-alert","url_meta":{"origin":1383,"position":2},"title":"Class 4 MHRA alert: Mirena inserters incorrectly mounted","author":"Admin","date":"14th February 2017","format":false,"excerpt":"Bayer plc, a global pharmaceutical company, has received two complaints with regards to its Mirena inserters. The complaints detail that the insertion tube was mounted inversely to the handle, and this has led to an inversion of the insertion depth scale, which may lead to incorrect insertion depth; consequently reducing\u2026","rel":"","context":"In "Medical"","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/medical.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/medical.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/medical.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/medical.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2723,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/empowering-rights-mhra-international-recognition-procedure","url_meta":{"origin":1383,"position":3},"title":"Empowering Rights: MHRA International Recognition Procedure","author":"Author","date":"27th February 2024","format":false,"excerpt":"Unveiling the MHRA International Recognition Procedure (IRP): The Medicines and Healthcare products Regulatory Agency (MHRA) has launched its groundbreaking new venture. The MHRA International Recognition Procedure (IRP) marks a significant milestone in regulatory affairs in our view. This new procedure, effective from January 1, 2024, is intended to streamline the\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"MHRA International Recognition Procedure","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/General-Blog-Image-4.jpg?fit=640%2C427&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/General-Blog-Image-4.jpg?fit=640%2C427&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/General-Blog-Image-4.jpg?fit=640%2C427&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":3187,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/claiming-compensation-for-incorrect-dose-content-statement-in-flutiform-inhaler-recall","url_meta":{"origin":1383,"position":4},"title":"Claiming Compensation for Incorrect Dose Content Statement in Flutiform Inhaler Recall","author":"Author","date":"28th October 2025","format":false,"excerpt":"A recall of Flutiform 250 micrograms \/ 10 micrograms per actuation pressurised inhalation suspension by CD Pharma Ltd has highlighted a labelling error. This issue reportedly revolves around an incorrect dose content statement on the outer carton of specific batches, as notified to the MHRA. The Group Action Lawyers specialises\u2026","rel":"","context":"In "Group Actions"","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"incorrect dose content statement","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/A-USED-DBL-DLL-MED-TIL-VM-replace-images-4-Copy-min.jpg?fit=734%2C587&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1697,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/valsartan-recall-widens","url_meta":{"origin":1383,"position":5},"title":"Valsartan recall widens","author":"Author","date":"7th December 2018","format":false,"excerpt":"The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA). Batches of products containing Valsartan that were supplied by Teva UK Ltd and Mylan are being recalled in the UK. This follows on from a drug alert earlier this year that was issued\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/health"},"img":{"alt_text":"drug recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=1383"}],"version-history":[{"count":5,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1383\/revisions"}],"predecessor-version":[{"id":1394,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1383\/revisions\/1394"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/1390"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=1383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=1383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=1383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}